Efficacy and quality of life for FOLFOX/bevacizumab +/− irinotecan in first-line metastatic colorectal cancer—final results of the AIO CHARTA trial

Hans‐Joachim Schmoll, Joseph Tintelnot, Fabian Maximilian Meinert et al.|British Journal of Cancer|2023

Cited by 11